S&P 500   3,191.46 (+1.15%)
DOW   26,631.08 (+2.09%)
QQQ   259.34 (+0.31%)
AAPL   386.54 (+1.21%)
MSFT   207.17 (+0.05%)
NVDA   413.66 (+2.88%)
CGC   17.31 (+0.06%)
BABA   247.64 (-1.60%)
MU   49.47 (+0.02%)
TSLA   1,525.51 (+1.90%)
GILD   77.17 (+0.64%)
BAC   24.00 (-0.83%)
S&P 500   3,191.46 (+1.15%)
DOW   26,631.08 (+2.09%)
QQQ   259.34 (+0.31%)
AAPL   386.54 (+1.21%)
MSFT   207.17 (+0.05%)
NVDA   413.66 (+2.88%)
CGC   17.31 (+0.06%)
BABA   247.64 (-1.60%)
MU   49.47 (+0.02%)
TSLA   1,525.51 (+1.90%)
GILD   77.17 (+0.64%)
BAC   24.00 (-0.83%)
S&P 500   3,191.46 (+1.15%)
DOW   26,631.08 (+2.09%)
QQQ   259.34 (+0.31%)
AAPL   386.54 (+1.21%)
MSFT   207.17 (+0.05%)
NVDA   413.66 (+2.88%)
CGC   17.31 (+0.06%)
BABA   247.64 (-1.60%)
MU   49.47 (+0.02%)
TSLA   1,525.51 (+1.90%)
GILD   77.17 (+0.64%)
BAC   24.00 (-0.83%)
S&P 500   3,191.46 (+1.15%)
DOW   26,631.08 (+2.09%)
QQQ   259.34 (+0.31%)
AAPL   386.54 (+1.21%)
MSFT   207.17 (+0.05%)
NVDA   413.66 (+2.88%)
CGC   17.31 (+0.06%)
BABA   247.64 (-1.60%)
MU   49.47 (+0.02%)
TSLA   1,525.51 (+1.90%)
GILD   77.17 (+0.64%)
BAC   24.00 (-0.83%)
Log in

NYSE:METMetlife Stock Price, Forecast & News

$37.75
+0.34 (+0.91 %)
(As of 07/14/2020 03:51 PM ET)
Add
Compare
Today's Range
$37.00
Now: $37.75
$37.94
50-Day Range
$33.34
MA: $36.97
$43.00
52-Week Range
$22.85
Now: $37.75
$53.28
Volume497,270 shs
Average Volume5.82 million shs
Market Capitalization$34.26 billion
P/E Ratio4.02
Dividend Yield4.98%
Beta1.34
MetLife, Inc. engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, tort settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, the company offers automobile, homeowners', and personal excess liability, as well as small business owners' property, liability, and business interruption insurance products. Further, it provides fixed annuities and pension products; medical and credit insurance products; variable, universal, term, endowment, and whole life insurance products; variable, and fixed and indexed-linked annuities; and protection against costs of long-term health care services. The company serves individuals, corporations and their employees, and other institutions and their members through independent agents, property and casualty specialists, sales forces, sales teams and relationship managers, and sponsoring organizations and affinity groups, as well as through career and independent agencies, bancassurance, direct marketing and e-commerce, brokers, and other third-party distribution channels. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.
Read More
Metlife logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.3Community Rank: 3.0Dividend Strength: 4.2Insider Behavior: 1.0Valuation: 2.5 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.39 out of 5 stars


Industry, Sector and Symbol

Industry Life insurance
Sub-IndustryLife & Health Insurance
SectorFinance
CUSIP59156R10
Phone212-578-9500

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$69.62 billion
Cash Flow$6.00 per share
Book Value$72.18 per share

Profitability

Net Income$5.90 billion

Miscellaneous

Employees49,000
Market Cap$34.26 billion
Next Earnings Date8/5/2020 (Confirmed)
OptionableOptionable

Receive MET News and Ratings via Email

Sign-up to receive the latest news and ratings for MET and its competitors with MarketBeat's FREE daily newsletter.

Metlife (NYSE:MET) Frequently Asked Questions

How has Metlife's stock been impacted by COVID-19 (Coronavirus)?

Metlife's stock was trading at $33.30 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, MET shares have increased by 13.4% and is now trading at $37.77. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Metlife?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Metlife in the last year. There are currently 4 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Metlife.

When is Metlife's next earnings date?

Metlife is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020. View our earnings forecast for Metlife.

How can I listen to Metlife's earnings call?

Metlife will be holding an earnings conference call on Wednesday, August 5th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Metlife's earnings last quarter?

Metlife Inc (NYSE:MET) issued its quarterly earnings data on Wednesday, May, 6th. The financial services provider reported $1.58 earnings per share for the quarter, beating the Zacks' consensus estimate of $1.44 by $0.14. The financial services provider had revenue of $15.54 billion for the quarter, compared to the consensus estimate of $16.38 billion. Metlife had a net margin of 12.37% and a return on equity of 8.85%. The business's revenue for the quarter was up .6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.48 earnings per share. View Metlife's earnings history.

How often does Metlife pay dividends? What is the dividend yield for Metlife?

Metlife declared a quarterly dividend on Wednesday, July 8th. Shareholders of record on Tuesday, August 4th will be paid a dividend of $0.46 per share on Monday, September 14th. This represents a $1.84 annualized dividend and a yield of 4.87%. The ex-dividend date of this dividend is Monday, August 3rd. View Metlife's dividend history.

How will Metlife's stock buyback program work?

Metlife announced that its board has approved a stock repurchase program on Thursday, November 1st 2018, which authorizes the company to buyback $2,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to buy up to 4.6% of its stock through open market purchases. Stock buyback programs are typically a sign that the company's board believes its stock is undervalued.

What price target have analysts set for MET?

9 analysts have issued 12-month price objectives for Metlife's shares. Their forecasts range from $32.00 to $47.00. On average, they expect Metlife's stock price to reach $41.43 in the next twelve months. This suggests a possible upside of 9.7% from the stock's current price. View analysts' price targets for Metlife.

Has Metlife been receiving favorable news coverage?

Headlines about MET stock have trended somewhat negative recently, according to InfoTrie Sentiment Analysis. The research group scores the sentiment of media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Metlife earned a coverage optimism score of -1.5 on InfoTrie's scale. They also gave news coverage about the financial services provider a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the next few days. View the latest news about Metlife.

Are investors shorting Metlife?

Metlife saw a decrease in short interest during the month of June. As of June 15th, there was short interest totaling 16,880,000 shares, a decrease of 6.9% from the May 31st total of 18,140,000 shares. Based on an average daily trading volume, of 8,070,000 shares, the short-interest ratio is presently 2.1 days. Approximately 2.2% of the shares of the company are short sold. View Metlife's Current Options Chain.

Who are some of Metlife's key competitors?

What other stocks do shareholders of Metlife own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Metlife investors own include AT&T (T), General Electric (GE), Walt Disney (DIS), Verizon Communications (VZ), IBM (IBM), Pfizer (PFE), Exxon Mobil (XOM), Bank of America (BAC), Johnson & Johnson (JNJ) and Intel (INTC).

Who are Metlife's key executives?

Metlife's management team includes the following people:
  • Mr. Michel A. Khalaf, CEO, Pres & Director (Age 55)
  • Mr. John Dennis McCallion CPA, Exec. VP & CFO (Age 45)
  • Mr. Steven Jeffrey Goulart, Exec. VP & Chief Investment Officer (Age 60)
  • Ms. Tamara L. Schock C.A., CPA, Exec. VP & Chief Accounting Officer (Age 47)
  • Mr. John Arthur Hall, Sr. VP & Head of Investor Relations

What is Metlife's stock symbol?

Metlife trades on the New York Stock Exchange (NYSE) under the ticker symbol "MET."

Who are Metlife's major shareholders?

Metlife's stock is owned by many different retail and institutional investors. Top institutional shareholders include Envestnet Asset Management Inc. (0.15%), Wedge Capital Management L L P NC (0.07%), State of Alaska Department of Revenue (0.02%), Gofen & Glossberg LLC IL (0.02%), Moody National Bank Trust Division (0.02%) and 6 Meridian (0.01%). Company insiders that own Metlife stock include Carlos M Gutierrez, John D Mccallion, Steven A Kandarian and Steven J Goulart. View institutional ownership trends for Metlife.

Which institutional investors are selling Metlife stock?

MET stock was sold by a variety of institutional investors in the last quarter, including MERIAN GLOBAL INVESTORS UK Ltd, 6 Meridian, Abner Herrman & Brock LLC, Gofen & Glossberg LLC IL, IFM Investors Pty Ltd, CENTRAL TRUST Co, Whittier Trust Co., and Addenda Capital Inc.. View insider buying and selling activity for Metlife.

Which institutional investors are buying Metlife stock?

MET stock was purchased by a variety of institutional investors in the last quarter, including Polaris Greystone Financial Group LLC, Envestnet Asset Management Inc., Wedge Capital Management L L P NC, Forte Capital LLC ADV, Unison Advisors LLC, State of Alaska Department of Revenue, Icon Wealth Partners LLC, and Verity & Verity LLC. View insider buying and selling activity for Metlife.

How do I buy shares of Metlife?

Shares of MET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Metlife's stock price today?

One share of MET stock can currently be purchased for approximately $37.77.

How big of a company is Metlife?

Metlife has a market capitalization of $34.28 billion and generates $69.62 billion in revenue each year. The financial services provider earns $5.90 billion in net income (profit) each year or $6.11 on an earnings per share basis. Metlife employs 49,000 workers across the globe.

What is Metlife's official website?

The official website for Metlife is www.metlife.com.

How can I contact Metlife?

Metlife's mailing address is 200 PARK AVENUE, NEW YORK NY, 10166. The financial services provider can be reached via phone at 212-578-9500.

This page was last updated on 7/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.